Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-LRRC15, PR-1498487 Vector   (CAT#: GTVCR-WQ2236MR)

This product GTVCR-WQ2236MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting LRRC15. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Chimeric; Humanized
RefSeq NM_001135057.3
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 131578
UniProt ID Q8TF66
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-LRRC15, PR-1498487 Vector (GTVCR-WQ2236MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ990MR IVTScrip™ pSP6-VEE-mRNA-Anti-IFNAR1&IFNAR2, CIFN Vector Vector CIFN
GTVCR-WQ1157MR IVTScrip™ pSP6-VEE-mRNA-Anti-CX3CL1, E-6011 Vector Vector E-6011
GTVCR-WQ289MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL1B, ACZ885 Vector Vector ACZ885
GTVCR-WQ1546MR IVTScrip™ pSP6-VEE-mRNA-Anti-MS4A1, IMMU-106 Vector Vector IMMU-106
GTVCR-WQ1212MR IVTScrip™ pT7-VEE-mRNA-Anti-CD19, FMC63 scFv-G4h-28-F9Z-TpERt CAR Vector Vector FMC63 scFv-G4h-28-F9Z-TpERt CAR
GTVCR-WQ115MR IVTScrip™ pT7-VEE-mRNA-Anti-AOC3, 8c10 Vector Vector 8c10
GTVCR-WQ690MR IVTScrip™ pSP6-VEE-mRNA-Anti-IGF, BI 836 Vector Vector BI 836
GTVCR-WQ430MR IVTScrip™ pSP6-VEE-mRNA-Anti-CALCRL, AMG 334 Vector Vector AMG 334
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.